← Open Payments lookup

SARAH LONG: Open Payments

NPI 1376825380 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,955 in 69 payments from 17 companies in 2025. Trend: 2023 $1,654 · 2024 $1,561 · 2025 $1,955

Food & beverage: $1,955
CompanyPaymentsAmount
ABBVIE INC.23$499
Janssen Biotech, Inc.12$498
Madrigal Pharmaceuticals4$267
Takeda Pharmaceuticals U.S.A., Inc.5$129
Gilead Sciences, Inc.4$99
GENZYME CORPORATION3$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$69
QOL Medical, LLC3$63
Regeneron Healthcare Solutions, Inc.2$53
Organon LLC2$38

Products named: TREMFYA, REZDIFFRA, SKYRIZI, RINVOQ, DUPIXENT, CREON, XIFAXAN, Sucraid.

Industry payments across IN — which companies pay providers there.